Inspire Medical Systems, Inc.

Valuation Analysis

About the Company

Inspire Medical Systems, Inc. en bref

Inspire Medical Systems, Inc. (INSP) is currently trading at 37,15 € with a market capitalization of 1,1 Md €. The trailing P/E ratio stands at 9.68x, with a forward P/E of 32.64x. The 52-week range spans from 33,92 € to 128,18 €; the current price is 71% below the yearly high. Year-over-year revenue growth stands at +1.6%. The net profit margin stands at 14.33%.

💰 Dividende

Inspire Medical Systems, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

12 analystes évaluent Inspire Medical Systems, Inc. (INSP) au consensus : Conserver. L'objectif de cours moyen est de 45,48 €, soit un potentiel de +22.43% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 34,00 € à 56,66 €.

Inspire Medical Systems, Inc. : la thèse d'investissement en détail

Inspire Medical Systems, Inc. (INSP) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 85.78%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 1.6%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Short interest sits at 16.81% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 22.43% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (16.81%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Inspire Medical Systems, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.